Literature DB >> 10485080

Pharmacokinetics and relative bioavailability of carboxyamido-triazole with respect to food and time of administration: use of a single model for simultaneous determination of changing parameters.

K S Bauer1, E C Kohn, R M Lush, S M Steinberg, P Davis, D Kohler, E Reed, W D Figg.   

Abstract

Carboxyamido-triazole (CAI) is an anti-invasive, antimetastatic, antiangiogenic agent in clinical development for cancer treatment. It has been postulated that food might enhance the oral absorption of micronized CAI based on an apparent discrepancy in steady state maximum concentrations when taken without regard to meals vs. fasting. The purpose of this study was to determine if a standardized meal affects the absorption and pharmacokinetics of this agent. Twelve patients with refractory cancers and good end organ function were randomized to receive two doses of CAI (250 mg/m2) with and without a standardized high fat meal. One cohort of 6 patients received these doses at 9 AM, and the remaining 6 patients received CAI at 9 PM. Blood was obtained prior to each dose, and serially thereafter. A series of pharmacokinetic (PK) models were fit to the concentration-time data. PK parameters were ultimately calculated using a model which allows simultaneous estimation of parameters from both test doses using nonlinear least squares analysis with ADAPT II. This model estimates independent absorption rate constants and relative fraction absorbed for each condition. AUC0-t was determined using the trapezoidal method, extrapolated to infinity, and used to calculate the relative bioavailability. No significant differences in PK parameters were noted between the morning and evening cohorts. However, the relative bioavailability, as measured by AUC0-infinity, of CAI was significantly increased when administered with a high fat meal compared to fasting (138.9 vs. 52.2 micrograms * hr/ml; p = 0.0005). The magnitude of the increase in relative bioavailability of CAI taken with food could have profound implications for patients who may inadvertently take this medication shortly after eating.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10485080     DOI: 10.1023/a:1020750923542

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  12 in total

1.  Effects of the calcium influx inhibitor carboxyamido-triazole on the proliferation and invasiveness of human prostate tumor cell lines.

Authors:  W J Wasilenko; A J Palad; K D Somers; P F Blackmore; E C Kohn; J S Rhim; G L Wright; P F Schellhammer
Journal:  Int J Cancer       Date:  1996-10-09       Impact factor: 7.396

2.  The use of non-parametric methods in the statistical analysis of the two-period change-over design.

Authors:  G G Koch
Journal:  Biometrics       Date:  1972-06       Impact factor: 2.571

3.  A program package for simulation and parameter estimation in pharmacokinetic systems.

Authors:  D Z D'Argenio; A Schumitzky
Journal:  Comput Programs Biomed       Date:  1979-03

4.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

5.  Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulations.

Authors:  E C Kohn; W D Figg; G A Sarosy; K S Bauer; P A Davis; M J Soltis; A Thompkins; L A Liotta; E Reed
Journal:  J Clin Oncol       Date:  1997-05       Impact factor: 44.544

6.  L651582: a novel antiproliferative and antimetastasis agent.

Authors:  E C Kohn; L A Liotta
Journal:  J Natl Cancer Inst       Date:  1990-01-03       Impact factor: 13.506

7.  Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers.

Authors:  E C Kohn; E Reed; G Sarosy; M Christian; C J Link; K Cole; W D Figg; P A Davis; J Jacob; B Goldspiel; L A Liotta
Journal:  Cancer Res       Date:  1996-02-01       Impact factor: 12.701

8.  Similarity of metabolism for CAI (NSC 609974) in human liver tissue in vitro and in humans in vivo

Authors: 
Journal:  Clin Cancer Res       Date:  1995-04       Impact factor: 12.531

9.  Angiogenesis: role of calcium-mediated signal transduction.

Authors:  E C Kohn; R Alessandro; J Spoonster; R P Wersto; L A Liotta
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

10.  Calcium influx modulates expression of matrix metalloproteinase-2 (72-kDa type IV collagenase, gelatinase A).

Authors:  E C Kohn; W Jacobs; Y S Kim; R Alessandro; W G Stetler-Stevenson; L A Liotta
Journal:  J Biol Chem       Date:  1994-08-26       Impact factor: 5.157

View more
  1 in total

Review 1.  Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy.

Authors:  Brahma N Singh; Bimal K Malhotra
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.